EHC

Encompass Health Corporation Healthcare - Medical Care Facilities Investor Relations →

NO
17.5% ABOVE
↓ Approaching Was 23.3% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $81.61
14-Week RSI 38
Rel. Volume (14w) This week's trading vs. the 14-week average 0.9x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.38

Encompass Health Corporation (EHC) closed at $95.86 as of 2026-03-20, trading 17.5% above its 200-week moving average of $81.61. The stock is currently moving closer to the line, down from 23.3% last week. The 14-week RSI sits at 38, indicating neutral momentum.

Trading volume is running at 0.9x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.38 ratio) is neutral — neither side is clearly dominating.

Over the past 2012 weeks of data, EHC has crossed below its 200-week moving average 24 times. On average, these episodes lasted 28 weeks. The average one-year return after crossing below was -0.7%, suggesting these dips have not historically been reliable buying opportunities for this stock.

With a market cap of $9.6 billion, EHC is a mid-cap stock. The company generates a free cash flow yield of 3.1%. Return on equity stands at 24.8%, indicating strong profitability. The stock trades at 3.9x book value.

Over the past 33.2 years, a hypothetical investment of $100 in EHC would have grown to $580, compared to $2683 for the S&P 500. EHC has returned 5.4% annualized vs 10.4% for the index, underperforming the broader market over this period.

Free cash flow has been growing at a 53.4% compound annual rate, with 4 consecutive years of positive cash generation.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: EHC vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After EHC Crosses Below the Line?

Across 20 historical episodes, buying EHC when it crossed below its 200-week moving average produced an average return of -0.9% after 12 months (median +10.0%), compared to +12.9% for the S&P 500 over the same periods. 50% of those episodes were profitable after one year. After 24 months, the average return was +14.0% vs +21.1% for the index.

Each line shows $100 invested at the moment EHC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

EHC has crossed below its 200-week MA 24 times with an average 1-year return of +-0.7% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Oct 1987Dec 1987815.7%+3.6%+1587.1%
Feb 1988Feb 198848.1%+4.3%+1423.9%
Apr 1988Jan 19894225.9%+1.1%+1440.4%
Feb 1989Mar 198953.3%+36.0%+1492.4%
Feb 1993Nov 19934135.8%+62.9%+574.9%
Sep 1998Sep 199810.4%-69.7%+57.5%
Sep 1998Jun 200114373.7%-38.7%+204.8%
Oct 2001Nov 2001411.4%-63.1%+136.0%
Jan 2002Mar 2002713.3%-66.2%+145.6%
Jul 2002Aug 2002431.5%-84.7%+201.3%
Aug 2002Mar 200618499.2%-39.7%+450.8%
May 2006Aug 20061317.0%-13.5%+569.5%
Nov 2006Nov 200613.1%-5.0%+603.0%
Jan 2007Jan 200711.3%-18.1%+580.3%
Mar 2007Nov 200914163.2%-21.9%+545.5%
Feb 2010Mar 201043.6%+30.5%+762.3%
Aug 2010Aug 201032.0%+11.9%+755.8%
Sep 2011Oct 2011517.5%+59.7%+861.7%
Nov 2011Jan 201299.2%+23.2%+778.7%
Feb 2016Feb 201623.8%+33.2%+350.4%
Mar 2020Mar 202018.2%+62.2%+155.8%
Oct 2021Mar 20222213.7%+9.9%+97.9%
Apr 2022Oct 20222717.3%+21.3%+86.3%
Mar 2023Apr 202345.0%+44.6%+83.8%
Average28+-0.7%

Frequently Asked Questions

Is EHC below its 200-week moving average?

No. Encompass Health Corporation (EHC) is currently 17.5% above its 200-week moving average of $81.61. It would need to fall to $81.61 to cross below the line.

What is EHC's 200-week moving average price?

Encompass Health Corporation's 200-week moving average is $81.61 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when EHC drops below its 200-week moving average?

EHC has crossed below its 200-week moving average 24 times in our data. The average one-year return after these crossings was -0.7%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 28 weeks on average.

Is EHC a good value right now?

Here's what our data says about EHC as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 38. Free cash flow yield is 3.1%. Return on equity is 24.8%. Price-to-book is 3.9x. This is not a buy or sell recommendation — always do your own research.

How does EHC compare to the S&P 500?

Over the past 33.2 years, $100 invested in EHC would have grown to $580, compared to $2683 for the S&P 500. That's 5.4% annualized vs 10.4% for the index. EHC has underperformed the broader market over this period.

Does EHC pay a dividend?

Yes. Encompass Health Corporation currently pays a dividend yield of 79.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-03-20